Home / NYT / Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?



By GINA KOLATA from NYT Health


Transplants, Drugs (Pharmaceuticals)
Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them? Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them? Reviewed by Moltivie on April 02, 2019 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.